Viavi Solutions (VIAV) Earnings Analysis
Viavi Solutions (VIAV) has no confirmed upcoming earnings date. Last quarter (2026-01-28) it beat with EPS 0.22 USD vs 0.19 USD est (+15.8%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -174.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VIAV next report earnings?
No confirmed upcoming earnings date is currently scheduled for VIAV. This page updates as the calendar is published.
VIAV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-01-28 | 0.22 USD | 0.19 USD | +15.8% | Beat |
| 2025-08-07 | 0.13 USD | 0.12 USD | +8.3% | Beat |
| 2025-05-01 | 0.15 USD | 0.12 USD | +25% | Beat |
| 2025-01-30 | 0.13 USD | 0.1 USD | +30% | Beat |
| 2024-10-31 | 0.06 USD | 0.06 USD | 0% | Beat |
| 2024-08-08 | 0.08 USD | 0.07 USD | +14.3% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
VIAV valuation and analyst view
| Trailing P/E | -174.15 |
|---|---|
| Trailing EPS | -0.2375 USD |
| Price / book | 11.58 |
| Dividend yield | 0.00% |
| Market cap | 10.53B |
| Analyst consensus | Buy (15 buy / 3 hold / 1 sell) |
| Avg price target | 66 USD |
Related research pages
Frequently asked questions
When is Viavi Solutions (VIAV)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for VIAV. This page updates as the calendar is published.
Did VIAV beat earnings last quarter?
In its 2026-01-28 report, VIAV posted EPS of 0.22 USD versus a 0.19 USD estimate — a beat of 15.8%.
What is VIAV's earnings track record?
Over the last 6 reported quarters with consensus data, VIAV beat estimates 6 times (100%).
What is VIAV's current P/E ratio and EPS?
VIAV trades at a trailing P/E of -174.15 on trailing EPS of -0.2375 USD.
What do analysts rate VIAV?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 15 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 66 USD.